【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: PIPELINE LANDSCAPE
PART 07: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Anticholinergics – Market size and forecast 2018-2023
• Beta-3 adrenergic agonists – Market size and forecast 2018-2023
• Other OAB therapeutics – Market size and forecast 2018-2023
• Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Advent of gene therapy
• Rising risk factors of OAB
• Growing geriatric population
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AbbVie Inc.
• Astellas Pharma, Inc.
• Camber Pharmaceuticals Inc.
• Endo International Plc
• KYORIN Holdings Inc.
• Merck & Co., Inc.
• Mylan NV
• Ono Pharmaceutical Co. Ltd.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
PART 15: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 16: EXPLORE TECHNAVIO
Exhibit 01: Vendors: Key offerings
Exhibit 02: Global pharmaceuticals market
Exhibit 03: Segments of global pharmaceuticals market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Some key clinical trials in global OAB therapeutics market
Exhibit 19: Product – Market share 2018-2023 (%)
Exhibit 20: Comparison by product
Exhibit 21: Anticholinergics – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Anticholinergics – Year-over-year growth 2019-2023 (%)
Exhibit 23: Beta-3 adrenergic agonists – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Beta-3 adrenergic agonists – Year-over-year growth 2019-2023 (%)
Exhibit 25: Other OAB therapeutics – Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Other OAB therapeutics – Year-over-year growth 2019-2023 (%)
Exhibit 27: Market opportunity by product
Exhibit 28: Customer landscape
Exhibit 29: Market share by geography 2018-2023 (%)
Exhibit 30: Geographic comparison
Exhibit 31: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: North America – Year-over-year growth 2019-2023 (%)
Exhibit 33: Top 3 countries in North America
Exhibit 34: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 36: Top 3 countries in Europe
Exhibit 37: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 39: Top 3 countries in Asia
Exhibit 40: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 41: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 42: Top 3 countries in ROW
Exhibit 43: Key leading countries
Exhibit 44: Market opportunity
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendors covered
Exhibit 49: Vendor classification
Exhibit 50: Market positioning of vendors
Exhibit 51: AbbVie Inc. – Vendor overview
Exhibit 52: AbbVie Inc. – Business segments
Exhibit 53: AbbVie Inc. – Organizational developments
Exhibit 54: AbbVie Inc. – Geographic focus
Exhibit 55: AbbVie Inc. – Key offerings
Exhibit 56: AbbVie Inc. – Key customers
Exhibit 57: Astellas Pharma Inc. – Vendor overview
Exhibit 58: Astellas Pharma Inc. – Business segments
Exhibit 59: Astellas Pharma Inc. – Organizational developments
Exhibit 60: Astellas Pharma Inc. – Geographic focus
Exhibit 61: Astellas Pharma Inc. – Key offerings
Exhibit 62: Astellas Pharma Inc. – Key customers
Exhibit 63: Camber Pharmaceuticals Inc. – Vendor overview
Exhibit 64: Camber Pharmaceuticals Inc. – Business segments
Exhibit 65: Camber Pharmaceuticals Inc. – Organizational developments
Exhibit 66: Camber Pharmaceuticals Inc. – Key offerings
Exhibit 67: Camber Pharmaceuticals Inc. – Key customers
Exhibit 68: Endo International Plc – Vendor overview
Exhibit 69: Endo International Plc – Business segments
Exhibit 70: Endo International Plc – Organizational developments
Exhibit 71: Endo International Plc – Geographic focus
Exhibit 72: Endo International Plc – Segment focus
Exhibit 73: Endo International Plc – Key offerings
Exhibit 74: Endo International Plc – Key customers
Exhibit 75: KYORIN Holdings Inc. – Vendor overview
Exhibit 76: KYORIN Holdings Inc. – Business segments
Exhibit 77: KYORIN Holdings Inc. – Organizational developments
Exhibit 78: KYORIN Holdings Inc. – Geographic focus
Exhibit 79: KYORIN Holdings Inc. – Segment focus
Exhibit 80: KYORIN Holdings Inc. – Key offerings
Exhibit 81: KYORIN Holdings Inc. – Key customers
Exhibit 82: Merck & Co. Inc. – Vendor overview
Exhibit 83: Merck & Co. Inc. – Business segments
Exhibit 84: Merck & Co. Inc. – Organizational developments
Exhibit 85: Merck & Co. Inc. – Geographic focus
Exhibit 86: Merck & Co. Inc. – Segment focus
Exhibit 87: Merck & Co. Inc. – Key offerings
Exhibit 88: Merck & Co. Inc. – Key customers
Exhibit 89: Mylan NV – Vendor overview
Exhibit 90: Mylan NV – Product segments
Exhibit 91: Mylan NV – Organizational developments
Exhibit 92: Mylan NV – Geographic focus
Exhibit 93: Mylan NV – Segment focus
Exhibit 94: Mylan NV – Key offerings
Exhibit 95: Mylan NV – Key customers
Exhibit 96: Ono Pharmaceutical Co. Ltd. – Vendor overview
Exhibit 97: Ono Pharmaceutical Co. Ltd. – Business segments
Exhibit 98: Ono Pharmaceutical Co. Ltd. – Organizational developments
Exhibit 99: Ono Pharmaceutical Co. Ltd. – Geographic focus
Exhibit 100: Ono Pharmaceutical Co. Ltd. – Key offerings
Exhibit 101: Ono Pharmaceutical Co. Ltd. – Key customers
Exhibit 102: Pfizer Inc. – Vendor overview
Exhibit 103: Pfizer Inc. – Business segments
Exhibit 104: Pfizer Inc. – Organizational developments
Exhibit 105: Pfizer Inc. – Geographic focus
Exhibit 106: Pfizer Inc. – Segment focus
Exhibit 107: Pfizer Inc. – Key offerings
Exhibit 108: Pfizer Inc. – Key customers
Exhibit 109: Teva Pharmaceutical Industries Ltd. – Vendor overview
Exhibit 110: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibit 111: Teva Pharmaceutical Industries Ltd. – Organizational developments
Exhibit 112: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibit 113: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibit 114: Teva Pharmaceutical Industries Ltd. – Key customers
Exhibit 115: Validation techniques employed for market sizing
Exhibit 116: Definition of market positioning of vendors
【レポート販売概要】
■ タイトル：過活動膀胱治療法の世界市場2019-2023■ 英文：Overactive Bladder Therapeutics Market by Product and Geography - Global Forecast and Analysis 2019-2023
■ 発行日：2019年8月28日
■ 調査会社：Technavio
■ 商品コード：IRTNTR31920
■ 調査対象地域：グローバル、アジア太平洋、ヨーロッパ、北米、その他
- Gilotrif (Non-Small Cell Lung Cancer)：市場予測と分析（～2022）Gilotrif (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients with specific biomarkers has begun to fragment the NSCLC treatment lan …
- 頭蓋顎顔面インプラントの世界市場：中顔面インプラント、下顎正顎インプラント、頭蓋/神経インプラント、代用骨移植片、ディストラクションシステム、完全TMJ置換装置、頭蓋フラップ固定装置、胸部固定装置、硬膜修復製品Craniomaxillofacial implants refers to implants used in the Craniomaxillofacial surgeries. Craniomaxillofacial surgery is performed to treat injuries, defects, and diseases in the head, neck, face, jaws, hard and soft tissues of the oral and maxillofacial region. It is internationally recognized surgical speciality. The major factors driving the growth of this market are increasing number of road …
- 世界の吸収式冷凍機市場：Global Absorption Chillers Market 2014-2018TechNavio forecasts The Global Absorption Chillers Market 2014-2018 with a CAGR of 3.94 percent for the period 2014-2018. Several driving factors and trends will contribute to this growth-all of which will be outlined with detail in this report. TechNavio’s analysts use a unique methodology to scrutinize individual vendor performance, trends, drivers and challenges, and a number of other factors t …
- 世界のITロボット自動化市場IT robotic automation gives enhanced adaptability to effectively increasing or diminishing production levels at low expense. In businesses where interest for items and administration is similar to the case with financial items, enhanced versatility offered by robotic automation serves to adequately scale throughput at a settled level of value and known administration levels. IT robotic automation …
- Botox (片頭痛/Migraine)：医薬品市場予測及び分析（～2023）Botox (Migraine) - Forecast and Market Analysis to 2023 Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected to lose exclusivity during the next few years, with the exception of Botox for chronic migraine, which is expected to maintain its leading position in terms of sales. However, reformulations of mature products as …
- 世界の搾乳器市場動向（2012-2016）TechNavio's analysts forecast the Global Breast Pump market to grow at a CAGR of 7.72 percent over the period 2012-2016. One of the key factors contributing to this market growth is the strong growth of the Breast Pumps Market in the US. The Global Breast Pump market has also been witnessing increasing awareness among emerging countries. However, small- and medium-sized vendors face high entry bar …
- 世界のMake-up市場におけるM&A動向（2014年2月）Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global make-up market during February 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global make-up market throughout the month. Additionally, the report provides an overview of all the partner …
- 民間ヘリコプターの世界市場2016-2026Visiongain assesses that the civil helicopter market is valued at $7,876m in 2016. Civil helicopters offer a number of capabilities that cannot be achieved with fixed wing aircraft. Vertical take-off and landing capabilities mean that helicopters can operate in areas that are remote, have difficult terrain characteristics or where ground transport infrastructure or airfield facilities are under-de …
- 企業合成アプリケーションモニタリングの世界市場予測：APIモニタリング、SAASアプリケーション、モバイルアプリケーション、ウェブアプリケーションMarketsandMarkets forecasts the enterprise synthetic application monitoring market size to grow from USD 919.2 Million in 2016 to USD 2,109.7 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 18.1%. Enterprise synthetic monitoring process is instrumental in methodically and proactively monitor the network and application performance using external agents, which intimates the actual end u …
- 自動給餌システムの世界市場予測（～2023年）“The automated feeding systems market is projected to grow at a CAGR of 7.6%.”The automated feeding systems market is estimated to account for nearly USD 5.1 billion in 2018 and is projected to grow at a CAGR of 7.6%, to reach nearly USD 7.4 billion by 2023. The market is driven by the increasing preference of farm owners to automate processes for reducing operating costs and losses associated wit …
- 急性呼吸不全症候群：治療薬のグローバル治験動向（2014年下半期）Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Acute Respiratory Distress Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Acute Respiratory Distress Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Respiratory Distress Syndro …
- 農薬市場：スリナムThis report is a comprehensive research of agrochemicals in Suriname. The first two chapters of the report feature the country profile by giving general information on Suriname and by thoroughly studying its economic state, (including key macroeconomic indicators and their development trends). The third chapter covers common business procedures in the country: from starting a project to closing a …
- ソノブイの世界市場2016-2020About Sonobuoy Sonobuoys are key aspects of naval forces and underwater acoustic research institutions. They are mainly deployed by ships and aircraft in the ocean to extract information about submarines of nemeses and mammals. Hydrophone sensors, sonar systems, radio transmitters, and receivers are some of the key components of sonobuoys. They are of three types: active, passive, and special purp …
- Enagas S.A.：石油・ガスバリューチェーン分析レポート2013Enagas S.A. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Enagas S.A." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Enagas S.A.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business …
- SandRidge Energy, Inc.：石油・ガスバリューチェーン分析レポート2013SandRidge Energy, Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "SandRidge Energy, Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “SandRidge Energy, Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The repor …
